Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
NDV-HXP-S is an inactivated COVID-19 vectored-vaccine virus using the Newcastle Disease Virus as basis and expressing S protein from SARS-CoV-2 stabilized in pre-fusion form with Hexapro technology. This vaccine was successfully tested in non-clinical study with a good safety profile and eliciting neutralizing antibodies against SARS-CoV-2. Clinical testing is conducted by an international consortium including three different manufacturers. Butantan, in Brazil, is one of them.
Epistemonikos ID: 068a1218651b3f74b5ef6078cd872a0c3e50e684
First added on: Aug 07, 2021